Wells Fargo & Company Nuvasive Inc Transaction History

Wells Fargo & Company

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$36.71 - $44.15 $417,429 - $502,029	11,371 Added 67.03%	28,336 $1.18 Million
Q1 2023 May 12, 2023	BUY	$36.81 - $48.12 $357,093 - $466,812	9,701 Added 133.55%	16,965 $700,000
Q4 2022 Feb 13, 2023	BUY	$35.68 - $44.71 $23,513 - $29,463	659 Added 9.98%	7,264 $299,000
Q3 2022 Nov 14, 2022	SELL	$42.51 - $54.02 $651,550 - $827,964	-15,327 Reduced 69.88%	6,605 $290,000
Q2 2022 Aug 12, 2022	SELL	$46.84 - $59.75 $1.24 Million - $1.59 Million	-26,534 Reduced 54.75%	21,932 $1.08 Million

Q1 2022 May 16, 2022	SELL	$48.09 - $57.79 $6.41 Million - $7.71 Million	-133,332 Reduced 73.34%	48,466 $2.75 Million
Q4 2021 Feb 14, 2022	SELL	$47.19 - $62.68 $6.17 Million - $8.19 Million	-130,680 Reduced 41.82%	181,798 $9.54 Million
Q3 2021 Nov 15, 2021	SELL	$56.91 - $67.81 $383,004 - $456,361	-6,730 Reduced 2.11%	312,478 $18.7 Million
Q2 2021 Aug 16, 2021	SELL	$64.02 - $71.72 $1.42 Million - $1.59 Million	-22,228 Reduced 6.51%	319,208 $21.6 Million
Q1 2021 May 13, 2021	SELL	$53.26 - $68.08 $1.9 Million - $2.43 Million	-35,673 Reduced 9.46%	341,436 $22.4 Million
Q4 2020 Feb 09, 2021	BUY	$43.41 - $56.51 $703,806 - $916,196	16,213 Added 4.49%	377,109 $21.2 Million
Q3 2020 Nov 05, 2020	SELL	$47.43 - $60.75 $146,416 - $187,535	-3,087 Reduced 0.85%	360,896 $17.5 Million
Q2 2020 Aug 13, 2020	SELL	$43.51 - $66.59 $346,426 - $530,189	-7,962 Reduced 2.14%	363,983 $20.3 Million
Q1 2020 May 14, 2020	BUY	$32.82 - $81.13 $12.2 Million - $30.2 Million	371,945 New	371,945 $18.8 Million

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.